Sergey A Shiryaev

Title: Innovations by Sergey A. Shiryaev

Introduction

Sergey A. Shiryaev is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of novel screening strategies for identifying binders that target enzymatic antigens. His work has implications for therapeutic and diagnostic applications, especially concerning viral infections.

Latest Patents

One of his key patents is titled "Screening strategies for the identification of binders." This invention discloses innovative methods for identifying binders that specifically target the active site of enzymatic antigens. Notably, it includes antigen-binding moieties that bind to the NS2B-NS3 Proteinase of the West Nile Virus. These binders are designed to inhibit the enzymatic activity of the proteinase, showcasing their potential in therapeutic and diagnostic applications. Sergey holds 1 patent in this area.

Career Highlights

Sergey A. Shiryaev is currently associated with MorphoSys AG, a company known for its focus on therapeutic antibodies. His work at MorphoSys AG has allowed him to collaborate with leading experts in the field, further enhancing the impact of his innovations.

Collaborations

Throughout his career, Sergey has worked alongside notable colleagues such as Christian Frisch and Achim Knappik. These collaborations have contributed to the advancement of research in the field of enzymatic antigens and their inhibitors.

Conclusion

Sergey A. Shiryaev's contributions to the field of biochemistry, particularly through his innovative patent on screening strategies for binders, highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications.